We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-7.49%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.45B
AUM Growth
-$331M
Cap. Flow
-$447M
Cap. Flow %
-18.22%
Top 10 Hldgs %
43.96%
Holding
111
New
16
Increased
20
Reduced
24
Closed
16

Top Buys

Rank Stock Value
1
MIRM icon
Mirum Pharmaceuticals
MIRM
+$42.3M
2
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$42.2M
3
AERI
Aerie Pharmaceuticals
AERI
+$35.2M
4
SWTX
SpringWorks Therapeutics
SWTX
+$24.8M
5
CNC icon
Centene
CNC
+$20.3M

Top Sells

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$27.7M
2
IMMU
Immunomedics Inc
IMMU
+$26M
3
STAA icon
STAAR Surgical
STAA
+$25.8M
4
NVRO
NEVRO CORP.
NVRO
+$25M
5
NVTA
Invitae Corporation
NVTA
+$23.4M

Sector Composition

Rank Sector Weight
1 Healthcare 71.17%
2 Financials 0.3%
3 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATEC icon
76
Alphatec Holdings
ATEC
$1.27B
$2.69M 0.11%
+536,517
New +$2.79M
SYBX
77
DELISTED
Synlogic
SYBX
$2.54M 0.1%
73,843
– –
AGRX
78
DELISTED
Agile Therapeutics
AGRX
$1.89M 0.08%
+796
New +$1.96M
CSTL icon
79
Castle Biosciences
CSTL
$725M
$1.67M 0.07%
+92,477
New +$2.05M
ALPN
80
DELISTED
Alpine Immune Sciences Inc
ALPN
$1.61M 0.07%
406,926
-8,982
-2% -$38.5K
VRAY
81
DELISTED
ViewRay, Inc.
VRAY
$1.1M 0.04%
+378,623
New +$2.24M
HYPD
82
Hyperion DeFi Inc
HYPD
$41.2M
$729K 0.03%
2,463
-1,287
-34% -$367K
ZVRA icon
83
Zevra Therapeutics
ZVRA
$711M
$477K 0.02%
+43,257
New +$782K
NEOS
84
DELISTED
Neos Therapeutics, Inc
NEOS
$475K 0.02%
320,993
– –
VYNE icon
85
VYNE Therapeutics
VYNE
$27M
$446K 0.02%
1,384
-1,372
-50% -$443K
TARA icon
86
Protara Therapeutics
TARA
$229M
$318K 0.01%
30,622
– –
CNST
87
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$152K 0.01%
23,600
-160,000
-87% -$1.34M
ACRS icon
88
Aclaris Therapeutics
ACRS
$778M
– –
-3,983,025
Closed -$8.72M
ADPT icon
89
Adaptive Biotechnologies
ADPT
$3.5B
– –
-70,000
Closed -$3.38M
CHWY icon
90
Chewy
CHWY
$9B
– –
-261,337
Closed -$9.15M
ELV icon
91
Elevance Health
ELV
$82.9B
– –
-53,000
Closed -$15M
INSP icon
92
Inspire Medical Systems
INSP
$1.53B
– –
-151,106
Closed -$9.16M
KIDS icon
93
OrthoPediatrics
KIDS
$501M
– –
-32,000
Closed -$1.25M
NTRA icon
94
Natera
NTRA
$37.6B
– –
-1,002,834
Closed -$27.7M
STAA icon
95
STAAR Surgical
STAA
$1.19B
– –
-876,512
Closed -$25.8M
NVRO
96
DELISTED
NEVRO CORP.
NVRO
– –
-386,000
Closed -$25M
SWAV
97
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
– –
-312,146
Closed -$17.8M
NVTA
98
DELISTED
Invitae Corporation
NVTA
– –
-995,312
Closed -$23.4M
SRNE
99
DELISTED
Sorrento Therapeutics, Inc.
SRNE
– –
-2,091,461
Closed -$5.58M
ATNX
100
DELISTED
Athenex, Inc. Common Stock
ATNX
– –
-31,093
Closed -$12.3M
1 2 3
4
5

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2019 Portfolio in Review

As of Q3 2019, Deerfield Management held 111 positions worth $2.45B, down 12% from $2.78B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Deerfield Management withdrew a net $447M in Q3 2019, closing 16 positions and reducing 24 holdings. Its most notable exit was Natera, an estimated $27.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, up from 68% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Deerfield Management opened a new position in Mirum Pharmaceuticals worth $34.7M.

  • Deerfield Management's largest Q3 2019 buy was Mirum Pharmaceuticals: 3,448,912 shares worth $34.7M.
  • Deerfield Management added most to Rhythm Pharmaceuticals in Q3 2019, an estimated $42.2M increase.
  • Deerfield Management's biggest Q3 2019 reduction was Immunomedics Inc, cutting an estimated $26M.
  • Deerfield Management fully exited Natera in Q3 2019, selling an estimated $27.7M.
  • Deerfield Management's ten largest holdings make up 44% of its $2.45B portfolio in Q3 2019.
  • Deerfield Management opened 16 new positions and closed 16 in Q3 2019.
  • Deerfield Management's portfolio value fell 12% quarter-over-quarter to $2.45B.

Based on Deerfield Management's 13F filing for Q3 2019, filed 14 Nov 2019.